Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.
Yannick CyrValérie LamantiaSimon BissonnetteMelanie BurnetteAurèle Besse-PatinAnnie DemersMartin WabitschMichel ChrétienGaétan MayerJennifer L EstallMaya SalehMay FarajPublished in: Physiological reports (2021)
Normocholesterolemic subjects with lower plasma PCSK9 and higher WAT surface-expression of LDLR and CD36 have higher WAT NLRP3 inflammasome activation and T2D risk factors. This may be due to LDL-induced inhibition of adipocyte function.